Overview

Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The scope of the trial is to assess the free progression rate at 2 months for each group of patients.
Phase:
Phase 2
Details
Lead Sponsor:
Centre Oscar Lambret
Treatments:
Cyclophosphamide
Megestrol
Megestrol Acetate